Learning About the New Definition of MASLD - Listen - GI Insights

Learning About the New Definition of MASLD

Listen now

Description

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Paul Kwo, MD Non-alcoholic fatty liver disease connoted that there's no alcohol contribution to the fat and didn't accurately convey the interplay between metabolic-driven cytosis, which can come from insulin resistance and all of the other metabolic dysfunction-associated inflammatory patterns, as well as the contributions of alcohol. So what do we know about patients who have metabolic dysfunction-associated steatotic liver disease (MASLD) and also consume alcohol? To learn more, join Dr. Peter Buch as he discusses this with Dr. Paul Kwo, Professor of Medicine and the Director of Hepatology at Stanford University.

More Episodes

See all »

Elderly Patients with IBD: Management Strategies and Care

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: David P. Hudesman, MD There’s been an increase in the elderly irritable bowel disease (IBD) population, and it’s estimated that a third of our overall IBD population will soon be over the age of 60. When managing and diagnosing these...

Published 05/16/24

GI Insights

Published 05/16/24

Educating Gastrointestinal Patients About the Benefits of Vaccination

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Francis Farraye, MD Patients with inflammatory bowel disease (IBD) have an increased risk of developing infections, and some may be preventable with a vaccine. Approximately 70 percent of patients with ulcerative colitis or Crohn’s...

Published 05/01/24